A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 2, 2013, Pages 211-222

  Mao, Qin ^a   Zhang, Yu ^a,b   Fu, Xiaoyue ^a   Xue, Jianxin ^a   Guo, Wenhao ^a   Meng, Maobing ^a   Zhou, Zongguang ^a   Mo, Xianming ^a   Lu, You ^a  

^a SICHUAN UNIVERSITY   (China)

^b Guizhou People's Hospital   (China)

Author keywords

CD133; Chemotherapeutic resistance; Colon cancer stem cells; Hypoxia

Indexed keywords

CD133 ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; FLUOROURACIL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; OXALIPLATIN; PIMONIDAZOLE; TRANSCRIPTION FACTOR CDX2; ANTINEOPLASTIC AGENT; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER RESISTANCE; CANCER STEM CELL; CELL COUNT; CELL HYPOXIA; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STEM CELL NICHE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; ANIMAL; CANCER STAGING; COLON TUMOR; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ADULT; AGED; ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; PEPTIDES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MLCS; MLOWN;

EID: 84874976801     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1310-3     Document Type: Article

References (42)

1. Axelson H, Fredlund E, Ovenberger M, Landberg G, Pahlman S (2005) Hypoxia-induced dedifferentiation of tumor cells - a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol 16(4-5):554-563
2. Bapat SA, Mali AM, Koppikar CB, Kurrey NK (2005) Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 65(8):3025
3. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3(7):730-737
4. Brown JM (2007) Tumor hypoxia in cancer therapy. Methods Enzymol 435:295-321
5. Brown JM, Giaccia AJ (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58(7):1408
6. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11(1):69-82
7. Collins A, Berry P, Hyde C, Stower M, Maitland N (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65(23):10946-10951. doi: 10.1158/0008-5472.CAN-05-2018
8. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, Colgan SP (2002) Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62(12):3387
9. Covello KL, Kehler J, Yu H, Gordan JD, Arsham AM, Hu CJ, Labosky PA (2006) HIF-2alpha regulates Oct-4 effects of hypoxia on stem cell function embryonic development and tumor growth. Genes Dev 20(5):557-570
10. Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5(4):275-284
11. Dontu G, El-Ashry D, Wicha MS (2004) Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab 15(5):193-197
12. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ (1997) Regulation of human placental development by oxygen tension. Science 277(5332):1669
13. Goethals L, Debucquoy A, Perneel C, Geboes K, Ectors N, De Schutter H, Penninckx F, McBride WH, Begg AC, Haustermans KM (2006) Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers. Int J Radiat Oncol Biol Phys 65(1):246-254
14. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U, Bondesson M (2005) Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9(5):617-628
15. Hamburger AW, Salmon SE (1977) Primary bioassay of human tumor stem cells. Science 197(4302):461-463
16. Harris AL (2002) Hypoxia-A key regulatory factor in tumour growth. Nat Rev Cancer 2(1):38-47
17. Hermann PC, Bhaskar S, Cioffi M, Heeschen C (2010) Cancer stem cells in solid tumors. Semin Cancer Biol 20(2):77-84
18. Horst D, Kriegl L, Engel J, Kirchner T, Jung A (2008) CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer 99(8):1285-1289
19. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60(5):277-300
20. Keith B, Simon MC (2007) Hypoxia-inducible factors, stem cells, and cancer. Cell 129(3):465-472
21. Krishnamurthy P, Ross DD, Nakanishi T, Bailey-Dell K, Zhou S, Mercer KE, Sarkadi B, Sorrentino BP, Schuetz JD (2004) The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 279(23):24218
22. LaBarge MA, Bissell MJ (2008) Is CD133 a marker of metastatic colon cancer stem cells? J Clin Investig 118(6):2021
23. Levesque JP, Winkler IG, Hendy J, Williams B, Helwani F, Barbier V, Nowlan B, Nilsson SK (2007) Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow. Stem Cells 25(8):1954-1965. doi: 10.1634/stemcells.2006-0688
24. Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15(6):501-513
25. Meyerhardt JA, Mayer RJ (2005) Systemic therapy for colorectal cancer. N Engl J Med 352(5):476-487
26. Moore KA, Lemischka IR (2006) Stem cells and their niches. Science 311(5769):1880
27. Nishi H, Nakada T, Kyo S, Inoue M, Shay JW, Isaka K (2004) Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol Cell Biol 24(13):6076
28. O'Brien CA, Pollett A, Gallinger S, Dick JE (2006) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123):106-110
29. Olive P, Durand R, Raleigh J, Luo C, Aquino-Parsons C (2000) Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia. Br J Cancer 83(11):1525
30. Omura K (2008) Advances in chemotherapy against advanced or metastatic colorectal cancer. Digestion 77(1):13-22
31. Pardal R, Clarke MF, Morrison SJ (2003) Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3(12):895-902
32. Parmar K, Mauch P, Vergilio JA, Sackstein R, Down JD (2007) Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Nat Acad Sci 104(13):5431
33. Platet N, Liu SY, Atifi ME, Oliver L, Vallette FM, Berger F, Wion D (2007) Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett 258(2):286-290
34. Pouyssegur J, Dayan F, Mazure NM (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441(7092):437-443
35. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105-111
36. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R (2006) Identification and expansion of human colon-cancer-initiating cells. Nature 445(7123):111-115
37. Seidel S, Garvalov BK, Wirta V, Von Stechow L, Schänzer A, Meletis K, Wolter M, Sommerlad D, Henze AT, Nistér M (2010) A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α. Brain 133(Pt 4):983-995
38. Semenza GL (2009) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29(5):625-634
39. - metastatic colon cancer cells initiate tumors. J Clin Investig 118(6):2111
40. Singh S, Hawkins C, Clarke I, Squire J, Bayani J, Hide T, Henkelman R (2004) Identification of human brain tumor initiating cells. Nature 432(7015):396-401. doi: 10.1038/nature03031
41. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema JP (2007) Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1(4):389-402
42. Yin T, Li L (2006) The stem cell niches in bone. J Clin Investig 116(5):1195